Cancer and men who have sex with men: A systematic review

The Lancet Oncology

Volumn 13, Issue 12, 2012, Pages

  Boehmer, Ulrike ^a   Cooley, Timothy P ^b   Clark, Melissa A ^c  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANUS CANCER; CANCER DIAGNOSIS; CANCER PREVENTION; CULTURAL FACTOR; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; KNOWLEDGE; LIVER CELL CARCINOMA; LUNG CANCER; MALE; MALE HOMOSEXUAL; MALIGNANT NEOPLASTIC DISEASE; MERKEL CELL TUMOR; NONHODGKIN LYMPHOMA; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; POLYOMA VIRUS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEXUAL ORIENTATION; SOCIAL ASPECT; SYSTEMATIC REVIEW; VACCINATION; WART VIRUS;

HOMOSEXUALITY, MALE; HUMANS; MALE; NEOPLASMS; RISK FACTORS; SURVIVAL RATE; VIRUS DISEASES;

EID: 84870160536     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70347-9     Document Type: Review

References (54)

1. Siegel R, Ward E, Brawley O, Jemal A Cancer statistics, 2011. CA Cancer J Clin 2011, 61:212-236.
2. Cancer survivors-United States, 2007. MMWR Morb Mortal Wkly Rep 2011, 60:269-272. Centers for Disease Control and Prevention.
3. Cancer control continuum National Cancer Institute, (accessed Oct 3, 2012). http://cancercontrol.cancer.gov/od/continuum.html.
4. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009, 199:1263-1269.
5. Daling JR, Madeleine MM, Johnson LG, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004, 101:270-280.
6. Nyitray AG, Carvalho da Silva RJ, Baggio ML, et al. Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study. J Infect Dis 2011, 203:49-57.
7. Nyitray AG, Carvalho da Silva RJ, Baggio ML, et al. Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study. J Infect Dis 2011, 204:1711-1722.
8. Moscicki AB, Durako SJ, Houser J, et al. Human papillomavirus infection and abnormal cytology of the anus in HIV-infected and uninfected adolescents. AIDS 2003, 17:311-320.
9. Guimaraes MD, Grinsztejn B, Melo VH, et al. Anal HPV prevalence and associated factors among HIV-seropositive men under antiretroviral treatment in Brazil. J Acquir Immune Defic Syndr 2011, 57(suppl 3):S217-S224.
10. Piketty C, Darragh TM, Da Costa M, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 2003, 138:453-459.
11. Sirera G, Videla S, Pinol M, et al. High prevalence of human papillomavirus infection in the anus, penis and mouth in HIV-positive men. AIDS 2006, 20:1201-1204.
12. Abramowitz L, Benabderrahmane D, Ravaud P, et al. Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors. AIDS 2007, 21:1457-1465.
13. Wilkin TJ, Palmer S, Brudney KF, Chiasson MA, Wright TC Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. J Infect Dis 2004, 190:1685-1691.
14. Weis SE, Vecino I, Pogoda JM, et al. Prevalence of anal intraepithelial neoplasia defined by anal cytology screening and high-resolution anoscopy in a primary care population of HIV-infected men and women. Dis Colon Rectum 2011, 54:433-441.
15. Silva IT, de Ribamar Araújo J, Andrade RV, et al. Anal cancer precursor lesions in HIV-positive and HIV-negative patients seen at a tertiary health institution in Brazil. Acta Cir Bras 2011, 26:64-71.
16. Piketty C, Selinger-Leneman H, Grabar S, et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS 2008, 22:1203-1211.
17. Brewer NT, Ng TW, McRee AL, Reiter PL Men's beliefs about HPV-related disease. J Behav Med 2010, 33:274-281.
18. Hernandez BY, Wilkens LR, Thompson PJ, et al. Acceptability of prophylactic human papillomavirus vaccination among adult men. Hum Vaccin 2010, 6:467-475.
19. McRee AL, Reiter PL, Chantala K, Brewer NT Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability?. Cancer Epidemiol Biomarkers Prev 2010, 19:1937-1944.
20. Atkinson J, Edlin BR, Engels EA, et al. Seroprevalence of human herpesvirus 8 among injection drug users in San Francisco. J Infect Dis 2003, 187:974-981.
21. Engels EA, Atkinson JO, Graubard BI, et al. Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis 2007, 196:199-207.
22. Mbulaiteye SM, Atkinson JO, Whitby D, et al. Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study. J Clin Virol 2006, 35:442-449.
23. Nascimento MC, Wilder N, Pannuti CS, Weiss HA, Mayaud P Molecular characterization of Kaposi's sarcoma associated herpesvirus (KSHV) from patients with AIDS-associated Kaposi's sarcoma in Sao Paulo, Brazil. J Clin Virol 2005, 33:52-59.
24. Renwick N, Dukers NH, Weverling GJ, et al. Risk factors for human herpesvirus 8 infection in a cohort of drug users in the Netherlands, 1985-1996. J Infect Dis 2002, 185:1808-1812.
25. Souza VA, Sumita LM, Freire W, et al. Prevalence of antibodies to human herpesvirus-8 in populations with and without risk for infection in Sao Paulo State. Braz J Med Biol Res 2004, 37:123-127.
26. Szalai E, Gerlei Z, Szlavik J, et al. Prevalence of human herpesvirus-8 infection in HIV-positive patients with and without Kaposi's sarcoma in Hungary. FEMS Immunol Med Microbiol 2005, 43:265-268.
27. Widmer IC, Erb P, Grob H, et al. Human herpesvirus 8 oral shedding in HIV-infected men with and without Kaposi sarcoma. J Acquir Immune Defic Syndr 2006, 42:420-425.
28. Kouri V, Eng SM, Rodriguez ME, et al. Seroprevalence of Kaposi's sarcoma-associated herpesvirus in various populations in Cuba. Rev Panam Salud Publica 2004, 15:320-325.
29. Crum NF, Wallace MR, Stephan K, et al. Correlates of human herpesvirus-8 seropositivity among US military members recently infected with human immunodeficiency virus. Sex Transm Dis 2003, 30:713-718.
30. Incidence of acute hepatitis B-United States, 1990-2002. MMWR Morb Mortal Wkly Rep 2004, 52:1252-1254. Centers for Disease Control and Prevention (CDC).
31. Franceschi S, Polesel J, Rickenbach M, et al. Hepatitis C virus and non-Hodgkin's lymphoma: findings from the Swiss HIV Cohort Study. Br J Cancer 2006, 95:1598-1602.
32. Wieland U, Silling S, Scola N, et al. Merkel cell polyomavirus infection in HIV-positive men. Arch Dermatol 2011, 147:401-406.
33. Blosnich J, Jarrett T, Horn K Disparities in smoking and acute respiratory illnesses among sexual minority young adults. Lung 2010, 188:401-407.
34. Rosa-Cunha I, Cardenas GA, Dickinson G, Metsch LR Addressing anal health in the HIV primary care setting: a disappointing reality. AIDS Patient Care STDS 2010, 24:533-538.
35. Heslin KC, Gore JL, King WD, Fox SA Sexual orientation and testing for prostate and colorectal cancers among men in California. Med Care 2008, 46:1240-1248.
36. Allardice GM, Hole DJ, Brewster DH, Boyd J, Goldberg DJ Incidence of malignant neoplasms among HIV-infected persons in Scotland. Br J Cancer 2003, 89:505-507.
37. Ebrahim SH, Abdullah AS, McKenna M, Hamers FF AIDS-defining cancers in Western Europe, 1994-2001. AIDS Patient Care STDS 2004, 18:501-508.
38. Atkinson JO, Biggar RJ, Goedert JJ, Engels EA The incidence of Kaposi sarcoma among injection drug users with AIDS in the United States. J Acquir Immune Defic Syndr 2004, 37:1282-1287.
39. Engels EA, Frisch M, Lubin JH, Gail MH, Biggar RJ, Goedert JJ Prevalence of hepatitis C virus infection and risk for hepatocellular carcinoma and non-Hodgkin lymphoma in AIDS. J Acquir Immune Defic Syndr 2002, 31:536-541.
40. Galceran J, Marcos-Gragera R, Soler M, et al. Cancer incidence in AIDS patients in Catalonia, Spain. Eur J Cancer 2007, 43:1085-1091.
41. Lanoy E, Dores GM, Madeleine MM, Toro JR, Fraumeni JF, Engels EA Epidemiology of nonkeratinocytic skin cancers among persons with acquired immunodeficiency syndrome in the United States. AIDS 2009, 23:385-393.
42. Mayor AM, Gomez MA, Rios E, Hunter RF Differences between patients with non-Hodgkin's lymphomas in a cohort of HIV/AIDS patients in Puerto Rico. Cell Mol Biol (Noisy-le-grand) 2003, 49:1145-1149.
43. Frisch M, Smith E, Grulich A, Johansen C Cancer in a population-based cohort of men and women in registered homosexual partnerships. Am J Epidemiol 2003, 157:966-972.
44. Cress RD, Holly EA Incidence of anal cancer in California: increased incidence among men in San Francisco, 1973-1999. Prev Med 2003, 36:555-560.
45. Motofei IG, Rowland DL, Popa F, Kreienkamp D, Paunica S Preliminary study with bicalutamide in heterosexual and homosexual patients with prostate cancer: a possible implication of androgens in male homosexual arousal. BJU Int 2011, 108:110-115.
46. Monforte A, Abrams D, Pradier C, et al. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS 2008, 22:2143-2153.
47. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 2006, 145:397-406.
48. Holly EA, Gautam M, Bracci PM Comparison of interviewed and non-interviewed non-Hodgkin's lymphoma (NHL) patients in the San Francisco Bay Area. Ann Epidemiol 2002, 12:419-425.
49. Boehmer U, Ozonoff A, Miao X An ecological analysis of colorectal cancer incidence and mortality: differences by sexual orientation. BMC Cancer 2011, 11:400.
50. Boehmer U, Miao X, Ozonoff A Cancer survivorship and sexual orientation. Cancer 2011, 117:3796-3804.
51. Parkin DM, Boyd L, Walker LC 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer 2011, 105(suppl 2):S77-S81.
52. Parkin DM The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006, 118:3030-3044.
53. Boehmer U, Miao X, Linkletter C, Clark MA Adult health behaviors in different age cohorts by sexual orientation. Am J Public Health 2012, 102:292-300.
54. Freeman HP Poverty, culture, and social injustice: determinants of cancer disparities. CA Cancer J Clin 2004, 54:72-77.